Transcriptome-driven drug discovery
Our platform uses AI to create detailed transcriptomic data on how different drugs affect gene activity, helping to guide better treatment decisions.
Faster therapeutic results based on proprietary gene expression data
Transcripta has built a high-resolution transcriptomic perturbation atlas using diverse small molecules. In conjunction with cell atlases, this allows us to identify opportunities across all human diseases. This data powers our frontier AI models to predict biological responses from candidate drug molecules.
Molecules are synthesized and validated in our lab, rapidly transforming insights into innovative therapies.
With whole-transcriptome resolution and our proprietary analytics platform, we are unlocking millions of therapeutic hypotheses per screen.